DRG: HYBRiD-XL in Kyrgyzstan

Sep 23, 2016 | News | 0 comments

Photo (right to left): Jenish Kimsanov, General Manager of URF and Maxi Saenger

Maximilian Saenger, son of the General Manager of DRG Germany (Wilhelm Saenger), traveled to Bishkek, capital of Kyrgyz Republic, during his summer vacation in August 2016. He took the chance to visit DRG´s distributor URF in Bishkek.

He was glad to see that URF already has installed 3 DRG:HYBRiD-XLs in this wonderful country in Central Asia. Up to now URF has registerd 28 assays for DRG´s unique automated instrument. At the moment they are in the process to register 6 additional assays, including the new kits Hepcidin 25 (bioactive) and Calprotectin!

Kyrgyzstan´s population is approximately 6 Million. The mountainous country is bordered by Kazakhstan to the north, Tajikistan to the south west, Uzbekistan to the west and China to the east.

DRG:HYBRiD-XL in customer´s lab

Gregory C. Guest

Gregory C. Guest

Gregory C. Guest is the International Marketing Manager located at DRG International’s worldwide headquarters in Springfield, NJ.
Gregory C. Guest

News and Updates

Sign Up for Our Newsletter

  • By submitting this form, you are granting: DRG International, Inc., 841 Mountain Avenue, Springfield, NJ, 07081, permission to email you. You may unsubscribe via the link found at the bottom of every email. (See our Email Privacy Policy (http://constantcontact.com/legal/privacy-statement) for details.) Emails are serviced by Constant Contact.

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.